Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes
Transplant Immunology
· Elsevier
Аннотация
Publication date: October 2026 Source: Transplant Immunology, Volume 98 Author(s): Ke Wang, Fei Wang, Ye Jin, Su-wan Liu, Yuan Feng, Yong-hui Ji, Jing-dong Zhou, Jun Qian
Читать у издателя →
Цитирование
Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes. // Transplant Immunology. – URL: https://www.sciencedirect.com/science/article/pii/S0966327426000924?dgcid=rss_sd_all
Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes. Transplant Immunology. https://www.sciencedirect.com/science/article/pii/S0966327426000924?dgcid=rss_sd_all
“Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes.” Transplant Immunology.
@article{article70116,
title = {Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes},
journal = {Transplant Immunology},
url = {https://www.sciencedirect.com/science/article/pii/S0966327426000924?dgcid=rss_sd_all}
}